Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

PARKINSON DISEASE

Pathogenetic insights into young-onset Parkinson disease

Nature Reviews Neurology volume 16, pages 245–246 (2020)Cite this article

Subjects

An understanding of the biochemical processes underlying Parkinson disease (PD) will be essential for the development of disease-modifying therapies. In a recent study, a novel biochemical phenotype of the disease was identified from analysis of inducible pluripotent stem cell-derived dopaminergic neurons from individuals with young-onset PD.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Marras, C. et al. Prevalence of Parkinson’s disease across North America. NPJ Parkinsons Dis. 4, 21 (2018).

    Article  CAS  Google Scholar 

  2. Toulorge, D., Schapira, A. H. V. & Hajj, R. Molecular changes in the postmortem parkinsonian brain. J. Neurochem. 139, 27–58 (2016).

    Article  CAS  Google Scholar 

  3. Kilarski, L. L. et al. Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson’s disease. Mov. Disord. 27, 1522–1529 (2012).

    Article  CAS  Google Scholar 

  4. Nalls, M. A. et al. Genetic risk and age in Parkinson’s disease: continuum not stratum. Mov. Disord. 30, 850–854 (2015).

    Article  CAS  Google Scholar 

  5. Malek, N. et al. Features of GBA-associated Parkinson’s disease at presentation in the UK Tracking Parkinson’s study. J. Neurol. Neurosurg. Psychiatry 89, 702–709 (2018).

    Article  Google Scholar 

  6. Laperle, A. H. et al. iPSC modeling of young-onset Parkinson’s disease reveals a molecular signature of disease and novel therapeutic candidates. Nat. Med. 26, 289–299 (2020).

    Article  CAS  Google Scholar 

  7. Burbulla, L. F. et al. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease. Science 357, 1255–1261 (2017).

    Article  CAS  Google Scholar 

  8. Robak, L. A. et al. Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease. Brain 140, 3191–3203 (2017).

    Article  Google Scholar 

  9. Balestrino, R. & Schapira, A. H. V. Glucocerebrosidase and Parkinson disease: molecular, clinical, and therapeutic implications. Neuroscientist 24, 540–559 (2018).

    Article  CAS  Google Scholar 

  10. Mullin, S. et al. Ambroxol for the treatment of patients with Parkinson disease with and without glucocerebrosidase gene mutations: a nonrandomized, noncontrolled trial. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2019.4611 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical and Movement Neurosciences, University College London Queen Square Institute of Neurology, London, UK

    Anthony H. V. Schapira & Huw R. Morris

Authors
  1. Anthony H. V. Schapira
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Huw R. Morris
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anthony H. V. Schapira.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schapira, A.H.V., Morris, H.R. Pathogenetic insights into young-onset Parkinson disease. Nat Rev Neurol 16, 245–246 (2020). https://doi.org/10.1038/s41582-020-0343-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41582-020-0343-5

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing